Abbott Laboratories

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 02:30:20 13/01/2026 am IST			After hours 06:30:00 am
124.64 ^USD	-1.02%		125.53	+0.71%

12/01	Medtronic Reports FDA Clearance for MiniMed Go App	MT
09/01	Bernstein Adjusts Price Target on Abbott Laboratories to $154 From $150, Maintains Outperform Rating	MT

Abbott Laboratories Appoints Nita Ahuja to Board of Directors

Published on 12/13/2025 at 02:41 am IST

S&P Capital IQ

Abbott Laboratories

-1.02%

On December 12, 2025, Nita Ahuja, M.D. was named to the Abbott Laboratories? (?Abbott?) Board of Directors.

Latest news about Abbott Laboratories

12/01	Medtronic Reports FDA Clearance for MiniMed Go App	MT
09/01	Bernstein Adjusts Price Target on Abbott Laboratories to $154 From $150, Maintains Outperform Rating	MT
09/01	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $152 From $157, Maintains Buy Rating	MT
05/01	Evercore ISI Adjusts PT on Abbott Laboratories to $144 From $142, Maintains Outperform Rating	MT
05/01	Abbott's New Libre Assist App Feature Taps A Top Need for People Living with Diabetes: In-The-Time Food Decision	CI
30/12	Alert from law firm on Exact Sciences-Abbott deal withdrawn	RE
22/12	Abbott Secures US FDA Approval for Volt Pulsed Field Ablation System for Heart Rhythm Disorder	MT
22/12	Abbott Gets FDA Approval for Volt Medical Device to Treat Arrhythmia	DJ
22/12	Abbott's Volt Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation	CI
18/12	Abbott's Amplatzer Piccolo? Delivery System Receives FDA Clearance for Premature Babies with A Hole in the Heart	CI
18/12	Abbott's Amplatzer Piccolo(TM) Delivery System Receives FDA Clearance	RE
18/12	Abbott Laboratories Receives FDA Clearance for Amplatzer Piccolo Delivery System	MT
13/12	Abbott Laboratories Appoints Nita Ahuja to Board of Directors	CI
12/12	Abbott Laboratories Declares 408th Consecutive Quarterly Cash Common Dividend, Payable on February 13, 2026	CI
12/12	Abbott Labs Maintains Royal Dividend Status With 6.8% Increase	DJ
12/12	Abbott Raises Quarterly Dividend to $0.63 a Share, Payable Feb. 13 to Holders of Record as of Jan. 15	MT
08/12	Abbott's Lingo Now on Android, Expanding Access to Real-Time Glucose Data	CI
05/12	PRESS DIGEST-New York Times business news - December 5	RE
04/12	Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement	CI
04/12	REUTERS NEXT -Mizuho's Katz sees 'fertile' conditions driving robust M&A market into 2026	RE
25/11	Abbott issues medical device correction for some glucose monitors in U.S.	RE
24/11	Abbott issues US device correction for some glucose monitors over faulty readings risk	RE
21/11	Health Care Down, But not by Much, Amid Deal Activity -- Health Care Roundup	DJ
21/11	Sector Update: Health Care Stocks Softer Late Afternoon	MT
21/11	Top Midday Gainers	MT

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (26.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments 22.3%); - nutrition products (20%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (18.6%). Net sales are distributed geographically as follows: the United States (38.9%), Germany (6.1%), China (5%), India (4.3%), Switzerland (4.2%), Japan (3.4%), the Netherlands (2.7%) and other (35.4%).

Employees

1,14,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

15/01 - Ex-dividend day

More about the company